Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 730.00
-2.00 (-0.27%)
Oct 26, 2026, 3:30 PM JST
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 29.65 billion as of October 26, 2026. It is the 21,051st most valuable company in the world and the 1,693rd biggest in Japan. Its market cap has increased by 48.37% in one year.
Market Cap
29.65B
Enterprise Value
26.30B
Revenue
2.52B
Global Rank
Country Rank
#1,693 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 29.65B, an increase of 394.72%. That is a compound annual growth rate of 8.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 29.65B | 17.36% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 72.13B |
| Heartseed | 61.31B |
| Cuorips | 57.37B |
| 3-D Matrix | 46.46B |
| Healios K.K. | 36.33B |
| Innovacell | 21.13B |
| RaQualia Pharma | 16.22B |
| Stella Pharma | 14.67B |